Foghorn’s AML/MDS Trial Moved From Partial To Full Clinical Hold

Uveal Melanoma Study Continues

 
• By Mandy Jackson
Innovation technology with security switch for information security management concept
Foghorn's Phase I trial of FHD-286 in AML/MDS is on a full clinical hold • Source: Shutterstock

More from Clinical Trials

More from R&D